IP Library Granted Patent US 11,229,684
Granted Patent B2
US 11,229,684 · App. 16/405,909 · Granted Jan 25, 2022

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Inventor: Mir Imran (Los Altos Hills, CA)
Assignee: RANI THERAPEUTICS, LLC
A61K38/27A61K9/0053A61K9/4808A61M25/10A61L27/54A61M31/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,229,684
App. No.
16/405,909
Granted
Jan 25, 2022
Kind
B2
Abstract

Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Many embodiments provide a swallowable device for delivering the agents. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade to release the drug into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Claims (31)

1. A method for delivering growth hormone to a patient in need thereof, the method comprising:

providing a swallowable enclosure having an interior, a delivery means, and a growth hormone preparation coupled to the delivery means, the growth hormone preparation comprising a therapeutically effective dose of growth hormone, the delivery means having a first configuration and a second configuration, the preparation being contained within the interior in the first configuration and advanced out of the interior and into a gastro-intestinal (GI) lumen wall in the second configuration so as to deliver the growth hormone preparation into the GI lumen wall, the enclosure protecting the growth hormone preparation from degradation by GI fluids, the growth hormone preparation supplied in the enclosure in a solid form which can be delivered from the enclosure into the GI lumen wall by the application of force on the preparation; and

triggering the delivery means within the GI lumen responsive to a condition in the lumen to deliver the growth hormone preparation from the enclosure into the GI lumen wall, wherein the dose of growth hormone is released into the patient's blood stream.

2. The method of claim 1 , wherein the GI lumen is the small intestine.

3. The method of claim 1 , wherein the GI lumen is the stomach.

4. The method of claim 1 , wherein the condition is a selected pH.

5. The method of claim 4 , wherein the pH is above about 7.1.

6. The method of claim 1 , wherein a weight percent of growth hormone in the growth hormone preparation comprises between about 2 to 10%.

7. The method of claim 1 , wherein a dose of growth hormone in the growth hormone preparation is in a range from about 0.1 to 4 mg.

8. The method of claim 7 , wherein the dose of growth hormone is in a range from about 0.2 to 1 mg.

9. The method of claim 1 , wherein the growth hormone is somatropin.

10. The method of claim 1 , wherein the growth hormone preparation further comprises at least one pharmaceutical excipient.

11. The method of claim 10 , wherein the at least one pharmaceutical excipient comprises at least one of a binder, a preservative or a disintegrant.

12. The method of claim 1 , further comprising retaining the growth hormone preparation within the GI lumen wall.

13. The method of claim 12 , wherein retaining comprises anchoring a portion of the growth hormone preparation in GI lumen wall tissue.

14. The method of claim 1 , wherein delivering the growth hormone preparation comprises applying a force to the growth hormone preparation.

15. The method of claim 14 , wherein the growth hormone preparation is advanced completely into the GI lumen wall by such application of force.

16. The method of claim 14 , wherein the growth hormone preparation is advanced through the GI lumen wall by such application of force.

17. The method of claim 14 , wherein the force is a mechanical force applied to a surface of the growth hormone preparation.

18. The method of claim 1 , wherein the growth hormone preparation produces a long-term release of the growth hormone.

19. The method of claim 18 , wherein the long term release of growth hormone is in a range of about 12 to 48 hours.

20. The method of claim 1 , further comprising:

using the dose of released growth hormone to treat growth hormone deficiency in a patient.

21. The method of claim 20 , wherein the growth hormone deficiency is associated with growth failure in a child.

22. The method of claim 1 , wherein the delivery means comprises an expandable balloon.

23. The method of claim 1 , wherein the delivery means comprises a spring.

24. A method for treating growth hormone deficiency in a patient, the method comprising:

providing a swallowable enclosure having an interior, a delivery means, and a growth hormone preparation coupled to the delivery means, the growth hormone preparation comprising a therapeutically effective dose of growth hormone, the delivery means having a first configuration and a second configuration, the preparation being contained within the interior in the first configuration and advanced out of the interior and into a gastro-intestinal (GI) lumen wall in the second configuration so as to deliver the growth hormone preparation into the GI lumen wall, the enclosure protecting the growth hormone preparation from degradation by GI fluids, the growth hormone preparation supplied in the enclosure in a solid form which can be delivered from the enclosure into the GI lumen wall by the application of force on the preparation;

triggering the delivery means within the GI lumen responsive to a condition in the lumen to deliver the growth hormone preparation from the enclosure into the GI lumen wall, wherein the dose of growth hormone is released into the patient's blood stream; and

using the dose of released growth hormone to treat the growth hormone deficiency in the patient.

25. The method of claim 24 , wherein the growth hormone deficiency is associated with growth failure in a child.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Dec 19, 2025
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: RANI THERAPEUTICS, LLC
Reel/Frame 073971/0117 →
SECURITY INTEREST Recorded Aug 9, 2022
From: RANI THERAPEUTICS, LLC
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
Reel/Frame 061131/0478 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2019
From: IMRAN, MIR
To: RANI THERAPEUTICS, LLC
Reel/Frame 049109/0696 →
Continuity (8)
Continuation 15824976 · Nov 28, 2017
Continuation 13538793 · Jun 29, 2012
Continuation In Part 12978233 · Dec 23, 2010
Continuation In Part 12978164 · Dec 23, 2010
Continuation In Part 12978301 · Dec 23, 2010
Provisional Application 61571632 · Jun 29, 2011
Provisional Application 61571641 · Jun 29, 2011
Related Publication 20200000885A1 · Jan 2, 2020
Cited By (2)
US 12,263,325 US 12,268,831